Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology

Figure 8

Molecular docking diagram. (a) Represents quercetin and AKT1 docking; (b) represents luteolin and GSK-3β docking; (c) represents (1Z,6Z)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione and JUN docking; (d) represents demethoxycurcumin and NFKB1docking; (e) represents quercetin and PIK3R1 docking; (f) represents linoleic acid and PPARα docking; (g) represents cis-3,5,3,4-tetrahydroxystilbene and RELA docking.

(a)

(b)

(c)

(d)

(e)

(f)

(g)